Robert G. Finizio - 10 May 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: CEO, Director
Signature: /s/ Robert G. Finizio
Issuer symbol: TXMD
Transactions as of: 10 May 2021
Net transactions value: -$70,405
Form type: 4
Filing time: 12 May 2021, 20:36:15 UTC
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Options Exercise		+158,334	+0.88%		18,059,334	10 May 2021	Direct	F1
transaction	TXMD	Common Stock	Sale	$70,405	-67,697	-0.37%	$1.04	17,991,637	11 May 2021	Direct	F2
holding	TXMD	Common Stock						2,000,000	10 May 2021	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXMD	Restricted Stock Units	Options Exercise	$0	-158,334	-33%	$0.000000	316,666	10 May 2021	Common Stock	158,334	$0.000000	Direct	F1, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
F2	The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3	The reported securities are held by the Robert Finizio Revocable Trust.
F4	Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F5	The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.